-
Messi magic as 'perfect' Miami thrash Cincinnati
-
Despite doubts over economy, Americans set for record holiday spending
-
Messi magic sends Miami into MLS conference final
-
Australian mining giant BHP drops Anglo American takeover bid
-
Real Madrid drop points at Elche, Atletico scrape win
-
Bellingham rescues Real Madrid draw at Elche
-
Mahomes rescue act saves Chiefs as Colts stumble
-
Finland's Valimaki wins first PGA title at RSM Classic
-
Pulisic fires AC Milan to derby glory as Roma move top of Serie A
-
50 children in Nigeria escape after kidnapping as 38 worshippers rescued
-
Giroud brace earns Lille win over Paris FC in Ligue 1
-
US says 'very optimistic' on Ukraine plan as Geneva talks end
-
No.1 Jeeno defends title at LPGA Tour Championship
-
Slovenia referendum rejects contested assisted dying law
-
Bolsonaro says ankle monitor tampering driven by 'paranoia'
-
Argentina boss Contepomi labels Curry a 'bully' after England loss
-
Sinner-less Italy see off Spain to complete Davis Cup hat-trick
-
'Exceptional' Eze deserved spotlight in Arsenal rout of Spurs: Arteta
-
Atletico snatch late win at Getafe with own-goal
-
US, Ukraine envoys hail 'good progress' at talks to end Russia war
-
Italy see off Spain to complete Davis Cup hat-trick
-
Arsenal's Eze revels in 'special' hat-trick after destroying Spurs
-
Ouedraogo stunner sends Leipzig second in Bundesliga
-
Ojomoh stars as England edge Argentina for 11th win in a row
-
Eze treble fuels Arsenal's derby rout of Spurs
-
'Wicked' sequel sees green in weekend-winning N. America debut
-
Ojomoh stars as England edge Argentina in Twickenham thriller
-
Israel says killed Hezbollah chief of staff in Beirut strike
-
Roma take top spot in Serie A ahead of Milan derby
-
Berrettini puts Italy on verge of third straight Davis Cup triumph
-
Trump blasts Ukraine for 'zero gratitude' amid talks to halt war
-
Ouedraogo stunner sends Leipzig second
-
What does US 'terrorist' designation for Venezuela mean?
-
Israel targets Hezbollah chief of staff in deadly Beirut strike
-
Scotland thrash Tonga in Autumn Nations finale
-
Three key Irish takeaways from Autumn Nations Series
-
Imperious Shiffrin swoops to 103rd win at Gurgl
-
Schmidt challenges Wallabies to 'roll up their sleeves' after gruesome year
-
Washington seeking to 'iron out' Trump proposal details with Ukrainians in Geneva
-
South African centurion Muthusamy celebrates 'awesome' Test journey
-
Brazil 'very concerned' about US naval build-up near Venezuela
-
Liverpool a 'mess' says Van Dijk
-
First blind women's T20 cricket World Cup boosts sport
-
France eye Dupont boost for Six Nations defence
-
McLaren boss apologises to Norris, Piastri for Vegas disqualification
-
G20 grapples with splintering world order
-
Verstappen wins big in Vegas with McLarens disqualified
-
Muthusamy, Jansen put South Africa on top in second India Test
-
Rubio lands in Geneva for talks on Ukraine plan
-
Norris and Piastri disqualified from Las Vegas GP
Featured
Last news
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the October 15, 2025 Special Meeting of Stockholders of Revelation Biosciences, Inc. (the "Company"), which was adjourned to October 29, 2025 has been canceled due to technical difficulty outside of the Company's control with stockholders being unable to vote all of their shares. The Company has decided to cancel the adjourned Special Meeting scheduled for today, October 29, at 12pm ET and to set a new record date of October 29, 2025 for a new Special Meeting of Stockholders to take place on December 3, 2025. The Company will issue new proxy materials to all stockholders of record as of the new record date in connection with this meeting. The Company encourages all stockholders to vote their shares promptly upon receipt of the proxy materials.
La Mer Beachfront Resort Unveils Its Newest Creation - a Dazzling "Sapphire Christmas" on the Jersey Shore as a New Holiday Landmark Arrives in Cape May
Standing at an impressive 30 feet and crowned with a three-foot illuminated star, the show-stopping tree is designed to dazzle and delight. Each branch will shimmer with 210 radiant sapphire lights, culminating in a breathtaking total of 32,340 lights that will bathe the resort in a mesmerizing sapphire glow throughout the holiday season.
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share major progress in the company's antiviral research in a video interview. The interview can be viewed at https://youtu.be/m_3Yk4_832E .
New Release Shines Light on a Shocking True Story of Justice Denied
USA v Raj by Dr. Raj Bothra and Jenifer DeBellis Released September 11, 2025
New Generation Consumer Group's Signature Apps in Talks to Acquire Revenue-Generating Subscription App Companies
PHOENIX, AZ / ACCESS Newswire / October 29, 2025 / New Generation Consumer Group (OTCID:NGCG) announced today that its subsidiary, Signature Apps, is in active discussions to acquire multiple revenue-generating app and service companies. The target companies operate on subscription-based models, delivering consistent, recurring revenues that align with Signature Apps' strategy to scale its digital product suite and expand its customer base.
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime
Specificity Signs LOI with Blackpearl Group to Build the World's Only Fully Integrated Ad Tech Stack, Launching a Direct Attack on Big Tech Fraud
TAMPA, FLORIDA / ACCESS Newswire / October 29, 2025 / Specificity (OTCID:SPTY), the leader in precision digital marketing, today announced it has signed a Letter of Intent (LOI) with New Zealand-based Blackpearl Group (BPG) to build and host a proprietary Private Data Platform- creating what companies describe as the world's only fully integrated ad tech stack. This move cements Specificity's path to major market disruption and positions the company to tackle the estimated $250 billion fraud problem plaguing the digital advertising industry, driven largely by bot and mechanical traffic.
Lex LasVegas to Emcee Compassion Center's Coalition for Patient Rights Inaugural Hoedown, Nov. 15 at Paradise Recreation Center
The Compassion Center and its Coalition for Patient Rights (CPR) tap Las Vegas mainstay Lex LasVegas to host a family-friendly day of music, advocacy, and community well-being on Saturday, November 15, 2025, 10 a.m.-6 p.m., at 4775 McLeod Dr., Las Vegas, NV 89121. In the lead-up, fans are invited to The Official 4Horsemen of Comedy Costume Party & Legendary 4Horseman Khalil Mack's Birthday on Wednesday, October 29, 2025, 9 p.m.-1 a.m.++ at Hola Habibi, with Blaque Tacos and a prize for Best Outfit.
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
DSMB Clearance to Proceed to the Next Dose Level of HG-CT-1 in Adult Patients, Opening Pediatric Recruitment, and Grant of Restricted Share Units to Hemogenyx Team
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
RLF-OD032 demonstrated bioequivalence to KUVAN® PowderStudy results support planned 505(b)(2) NDA submission in early 2026
'Catastrophic' hurricane slams Jamaica with fierce winds and rain
Hurricane Melissa ripped up trees and knocked out power after making landfall in Jamaica on Tuesday as one of the most powerful hurricanes on record, inundating the island nation with rains that threaten flash floods and landslides.
At least 64 killed in war-like Rio drug raids
Bodies piled up in poor neighborhoods of Rio de Janeiro on Tuesday as police launched their biggest ever raids on the city's drug traffickers, leaving at least 64 dead in war-like scenes.
At least 64 killed in Rio drug raid
Hundreds of heavily armed Brazilian police raided slum areas of Rio in a drug raid Tuesday, touching off firefights likened to scenes from a war and leaving at least 64 people dead, Brazilian officials said.
French prosecutors seek suspended jail terms in Brigitte Macron cyberbullying case
French prosecutors on Tuesday sought suspended prison terms of three to 12 months for defendants accused of cyberbullying First Lady Brigitte Macron by spreading unsubstantiated claims about her gender.
At least 18 suspects killed in Rio anti-drug raid: governor
At least 18 suspects and some police officers were killed Tuesday during a massive anti-drug raid in Rio de Janeiro, Brazilian authorities said, as prolonged gun battles erupted and demolition vehicles destroyed street barricades.
Giant Hurricane Melissa hours from bullseye hit on Jamaica
Hurricane Melissa was only hours away Tuesday from expected landfall on Jamaica, bringing devastating flooding and winds that officials warn will smash the small Caribbean nation's infrastructure.
The Voice of the Martyrs Releases Daniel and Aline: Democratic Republic of the Congo, a Short Film for 2025 International Day of Prayer for Persecuted Christians
BARTLESVILLE, OK / ACCESS Newswire / October 28, 2025 / The Voice of the Martyrs (VOM) has released a new short feature film telling the powerful story of Daniel and Aline, two courageous Congolese Christians bringing hope and healing to fellow believers traumatized by kidnapping, violence and loss in the Democratic Republic of the Congo (DRC).
Desert Oasis Healthcare Expands Maternal Health Resources with New Maternal Health Educator Position and Updated Video Education Series
DOHC strengthens its commitment to mothers and families through expanded education and personalized prenatal support
Newsmax to Report Third Quarter 2025 Financial Results
BOCA RATON, FL / ACCESS Newswire / October 28, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Thursday, November 13, 2025, after the U.S. stock market closes.
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ:SBFM) is quickly establishing which side of that line it's on. After scoring another major regulatory win, that position certainly isn't one of many in the crowd. On Tuesday, the company announced that it had secured Health Canada authorization to commercialize domperidone through its Nora Pharma subsidiary, a milestone that not only expands its commercial reach but also validates its growing track record of revenue-generating execution.
Who is Javad Sajan?
Javad Sajan is the best plastic surgeon in Seattle.
Vanderbilt Report NextTrip CEO Interview: NextTrip Builds What Traditional Travel Companies Couldn't
BRISTOL, TN / ACCESS Newswire / October 28, 2025 / Most online travel agencies can't prove their advertising works.
Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA
Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage.
Medical Care Technologies Inc. (OTC PINK:MDCE) Nears Completion of AI-Powered App Targeting the $4.5 Billion Global Nutrition & Recipe Market
MESA, ARIZONA / ACCESS Newswire / October 28, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has entered its final development phase. The app uses image recognition to create recipes and also analyzes nutrition data directly from food photos. MDCE plans to deploy the app in 175 countries and in over 30 languages.
Dolphin (NASDAQ:DLPN) Named One of Crain's Best Places to Work in NYC 2025
NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Dolphin (NASDAQ:DLPN) is proud to announce it has been recognized by Crain's New York Business as one of the Best Places to Work in New York City for 2025. The annual ranking honors companies that go above and beyond in creating workplaces defined by collegiality, collaboration, and care. Employers are evaluated on leadership, culture, professional development, benefits, and employee satisfaction.
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
DENVER, CO / ACCESS Newswire / October 28, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that the method of use patent (U.S. Patent No. 7,538,116) for EXXUATM (gepirone) extended-release tablets ("EXXUA") has been extended through September 2, 2030 under 35 U.S.C. 156. The patent extension further expands upon the new chemical entity ("NCE") exclusivity period granted by the United States Food and Drug Administration ("FDA"). Gepirone is an NCE, and EXXUA is the first-in-class selective serotonin 5HT1a receptor agonist approved by the FDA for the treatment of major depressive disorder ("MDD") in adults.
The NITE FLAG XL Launches October 28, 2025 - The Flag of the 21st Century
THE FUTURE OF FLAGS IS NOW- THE NITE FLAG COMPANY"Always Waves. Never Sags. Lights Up the Night."
Modular Medical Announces Ongoing Progress to Obtain CE Mark
Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026
VSee Awarded US Department of Health & Human Services FedRAMP High ATO
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS). The authorization also allows other federal agencies to use VSee where FedRAMP High is required.
Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.